Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Par Propranolol vs Inderal-LA
NCT00653120Phase 2Completed
- Sponsor
- Par Pharmaceutical
- Start
- May 2005
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of propranolol in hypertension (HTN), angina pectoris and migraine (2 arms), sponsored by Par Pharmaceutical. Primary endpoint: Rate and Extent of Absorption at 24 Hours. Started May 2005; status: completed.
02
Drugs
propranolol
03
Conditions
hypertension (HTN)angina pectorismigraine
Beyond the preview
Go deeper on NCT00653120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653120.